Análisis de la correlación entre la calidad de la prescripción de antipsicóticos y el estado clínico en pacientes con esquizofrenia

Herz, 2003, Guías clínicas para el tratamiento de los trastornos psiquiátricos Leheman, 1998, Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations, Schizophrenia Bulletin, 24, 1, 10.1093/oxfordjournals.schbul.a033302 Mc Evoy, 1999, Tre Expert Consensus Guidelines Series: treatment of schizophrenia, J Clin Psychiatry, 60, 1 Miller, 1999, The Texas Medication Algorithm Proyect (TMAP): Schizophrenia algorithm, J Clin Psychiatry, 60, 649, 10.4088/JCP.v60n1002 Geddes, 2000, Atypical antipsychotics in the treatment of schizophrenia: a systematic overview and meta-regresión análisis, BMJ, 321, 1371, 10.1136/bmj.321.7273.1371 Leucht, 2002, Amisulpride, an unusual “atypical” antipsychotic: a meta-analysis of randomised controlled trials, Am J Psychiatry, 159, 180, 10.1176/appi.ajp.159.2.180 Kissling, 2001, Quality management in psychiatry, Int Clin Psychopharmacol, 16, S15, 10.1097/00004850-200104003-00003 Salinas, 1995, Evaluación del uso de antipsicóticos y antiparkinsonianos en pacientes crónicos institucionalizados, Farm Hosp, 19, 137 Marder, 2002, Can clinical practice guide a research agenda?, Schizophrenia Bulletin, 28, 127, 10.1093/oxfordjournals.schbul.a006915 2002 Colaborating Centre for Drug Statistics Methodology, ATC/DDD Index 2003; en http://www.whocc.no/atcddd/indexdatabase/acceso10/05/2003. Clasificación anatómica de especialidades ATC 2003, en Catálogo de especialidades farmacéuticas 2003. Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, 2003. Kaplan, 1998 Bazire S. Psychotropic drug directory 2002. Salisbury: Quay Books, 2002. Marcos, 1973, The effect of interview language on the evaluation of psychopathology in Spanish-American schizophrenic patients, Am J Psychiat, 130, 549, 10.1176/ajp.130.5.549 Bech, 1988, Breve compendio de las escalas de evaluación para los estados de ansiedad, depresión, manía y esquizofrenia con los síndromes correspondientes en el DMS-III, Acta Psychiatr Scand, 73, 326 G-Stat, programa de análisis estadístico, versión 1.1, GlaxoSmithKline SA. http://www.e-pfb.com/ebiometria/g-stat/index.html; acceso 10/05/2003. Lambert, 2003, Medical comorbidity in schizophrenia, Med J Aust, 178, S67 Pantelis, 2003, Managing ptients with “treatment-resistant” schizophrenia, Med J Aust, 178, S62 Blasco, 1995, Prevalencia de movimientos anormales –discinesias tardías– entre pacientes tratados con neurolépticos, Farm Hosp, 19, 355 Day, 1998, A comparison of patients’ and prescribers’ beliefs about neuroleptic side-effects: prevalence, distress and causation, Acta Psychiatr Scand, 97, 93, 10.1111/j.1600-0447.1998.tb09969.x Thornley, 1998, Content and quality of 2000 controlled trials in schizophrenia over 50 years, BMJ, 317, 1181, 10.1136/bmj.317.7167.1181 Morrison, 2000, The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice, Aust N Z J Ment Health NURS, 94, 166, 10.1046/j.1440-0979.2000.00181.x Fajardo, 2001, Uso de Psicofármacos en el Hospital Universitario de San Juan, Aten Farm, 3, 414 Ramos, 1997, Psicopatología en una unidad psiquiátrica de corta estancia Buchanan, 2002, Relationship of the use of adjuntive pharmacological agents to symptoms and level of function in schizophrenia, Am J Psychiatry, 159, 1035, 10.1176/appi.ajp.159.6.1035 Ungvari, 2002, The pharmacological treatment of schizohrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999, Br J Clin Pharmacol, 54, 437, 10.1046/j.1365-2125.2002.01668.x Thomson, 1994, The use of high-dose antipsychotic medication, Br J Psych, 164, 448, 10.1192/bjp.164.4.448 Valenstein, 2001, Delays in adopting evidence-bases dosages of conventional antipsychotics, Psychiatric Services, 52, 1242, 10.1176/appi.ps.52.9.1242 Dickey, 2003, Guideline recommendations for treatment of schizophrenia, the impact of managed care, Arch Gen Psychiatry, 60, 340, 10.1001/archpsyc.60.4.340 Walkup, 2000, Patients with schizophrenia at risk for excessive antipsychotic dosing, J Clin Psychiatry, 61, 344, 10.4088/JCP.v61n0504 Owen, 2003, Clinical practice variations in prescribing antipsychotics for patients with schizophrenia, Am J Med Qual, 18, 140, 10.1177/106286060301800402 Remington, 2001, Antipsychotic dosing patterns for schizophrenia in three treatment settings, Psychiatric Services, 52, 96, 10.1176/appi.ps.52.1.96 Díaz, 2002, Excessive antipsychotic dosing in 2 US State hospitals, J Clin Psychiatry, 63, 998, 10.4088/JCP.v63n1107 Smith, 1994, Lower-dose therapy with traditional neuroleptics in chronically hopsitalized schizophrenic patients, Arch Gen Psychiatry, 51, 427, 10.1001/archpsyc.1994.03950050087011 Petel, 2003, Psychiatrist's attitudes to maintenance medication for patients with schizophrenia, Psychol Med, 33, 83, 10.1017/S0033291702006797 Clark, 2002, Recent Trends in Antipsychotic Combination Therapy of Schizophrenia and Schizoaffective Disorder: Implications for State Mental Health Policy, Schizophrenia Bulletin, 28, 75, 10.1093/oxfordjournals.schbul.a006928 Carpenter, 1999, Diazepam treatment of early signs of exacerbation in schizophrenia, Am J Psychiatry, 156, 299, 10.1176/ajp.156.2.299 Wolkowitz, 1991, Benzodiazepines in the treatment of schizophrenia: a review of reappraisal, Am J Psychiatry, 148, 714, 10.1176/ajp.148.6.714 Altamura, 1987, Clonazepam/haloperidol combination therapy in schizophrenia: a double blind study, Acta Psychiatr Scand, 76, 702, 10.1111/j.1600-0447.1987.tb02942.x Hirose, 2002, Immediate effect of intravenous diazepam in neuroleptic-induced acute akathisia: an open-label study, J Clin Psychiatry, 63, 524, 10.4088/JCP.v63n0610 Ashton HC. Guidelines for the rational use of benzodiazepines. Department of psychiatry. The Royal Victoria Infirmary. www.benzo.org.uk. ; acceso 10/05/2003. Fraser, 1998, Use and abuse of benzodiazepines, Ther Drug Monit, 20, 481, 10.1097/00007691-199810000-00007 Davison, 2001, Pharmacotherapy of generalized anxiety disorder, J Clin Psychiatry, 62, S46 Gorgels, 2001, Long-term use of benzodiazepines, Ned Tijdschr Geneeskd, 145, 1342 Grunstein, 2002, Insomnia. Diagnosis and management, Aust Fam Physician, 31, 995 Whitehead, 2003, Antidepressants for the treatment of depression in people with schizophrenia: a systematic review, Psychol Med, 33, 589, 10.1017/S0033291703007645 Stahl, 2002, Antipsychotic polypharmacy: evidence bases or eminence based?, Acta Psych Scand, 106, 321, 10.1034/j.1600-0447.2002.2e011.x Tapp, 2003, Combinación de antipsicóticos en la práctica clínica, Psychiatric Services (Ed Esp), 2, 53 Weissman, 2002, 28 Covell, 2002, Antipsychotic Prescribing practices in Connecticut's public Mental Health system: Rates of Changing Medications and Prescribing Styles, Schizophrenia Bulletin, 28, 17, 10.1093/oxfordjournals.schbul.a006920 Marchlewski, 1994, Anticholinergic síndrome. Avoidig misdiagnosis, J Psychosoc Nurs ment Health Serv, 32, 22, 10.3928/0279-3695-19940901-09 Flórez, 1997 Stahl, 2002, Psicofarmacología esencial Kirchner, 2000, Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose, International Journal for Quality in Health Care, 12, 475, 10.1093/intqhc/12.6.475 Leucht, 2003, New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis, Lancet, 361, 1581, 10.1016/S0140-6736(03)13306-5